Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DR26FQST9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,630
Award facts
- Contract value 100% obligated
- $10,629.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,629.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The award, issued on November 18, 2025, with an ultimate completion date of December 10, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (IDC) under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036.
The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to provide the Department of Defense with comprehensive pharmaceutical and medical supply support through multiple regional prime vendor contractors. DMS Pharmaceutical Group's selection as a single-award IDC holder positions the company as a critical supplier for DoD healthcare operations globally, authorizing the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support military healthcare facilities worldwide. The vendor's established performance across numerous pharmaceutical product lines and delivery orders demonstrates capability to fulfill the specialized medical supply requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FQST9?
SPE2DR26FQST9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FQST9 worth?
The government has obligated $10,630 on SPE2DR26FQST9.
Is contract SPE2DR26FQST9 an order under another contract?
Yes. SPE2DR26FQST9 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.
Was contract SPE2DR26FQST9 competed?
The extent of competition for SPE2DR26FQST9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award